Cite
HARVARD Citation
Hainsworth, J. et al. (n.d.). Paclitaxel/carboplatin with or without sorafenib in the first‐line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute. Cancer medicine. pp. 673-681. [Online].